Trial no.:
|
PACTR201902599405211 |
Date of Approval:
|
12/02/2019 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Long acting penicillin use in pregnant females with history of unexplained prelabor rupture of membranes |
Official scientific title |
Long acting penicillin use in pregnant females with history of unexplained prelabor rupture of membranes |
Brief summary describing the background
and objectives of the trial
|
Premature rupture of membranes (PROM) refers to rupture of the fetal membranes prior to the onset of labor, at any gestational age and is associated with an increased risk of ascending infection. Infection and inflammation likely explains why membranes break earlier than they are supposed to. In some studies, bacteria have been found in the amniotic fluid in about one-third of cases of PROM. Even if testing of the amniotic fluid is normal, a subclinical infection may still be contributing. In response to infection, the body creates inflammation by making chemicals (ex: cytokines) that weaken the fetal membranes and put them at risk for rupture . The fetal membranes serve as a barrier to ascending infection. Once the membranes rupture, both the mother and fetus are at risk of infection and of other complications. Fetal risk is related primarily to the gestational age. Preterm PROM is associated with a 4- fold increase in perinatal mortality and a 3-fold increase in neonatal morbidity, including respiratory distress syndrome, poly microbial intra-amniotic infection, intraventricular hemorrhage, and neonatal deaths . Long acting penicillin as a broad spectrum antibiotic could protect against bacterial colonization that may predispose to infection. Our aim is to evaluate the effect of Long acting penicillin use in pregnant females with history of unexplained prelabor rupture of membranes as a prophylaxis against bacterial colonization and recurrent prelabor rupture of membranes |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Obstetrics and Gynecology,Pregnancy and Childbirth |
Sub-Disease(s) or condition(s) being studied |
Unexplained prelabor rupture of membranes |
Purpose of the trial |
Prevention |
Anticipated trial start date |
15/02/2019 |
Actual trial start date |
15/02/2019 |
Anticipated date of last follow up |
31/10/2019 |
Actual Last follow-up date |
31/10/2019 |
Anticipated target sample size (number of participants) |
100 |
Actual target sample size (number of participants) |
100 |
Recruitment status |
Not yet recruiting |
Publication URL |
|
|